- Home
- ORGO vs CHPT Comparison
ORGO vs CHPT Comparison
Compare ORGO & CHPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- CHPT
- Stock Information
- Founded
- ORGO 1985
- CHPT 2007
- Country
- ORGO United States
- CHPT United States
- Employees
- ORGO N/A
- CHPT N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- CHPT Industrial Specialties
- Sector
- ORGO Health Care
- CHPT Consumer Discretionary
- Exchange
- ORGO Nasdaq
- CHPT Nasdaq
- Market Cap
- ORGO 376.8M
- CHPT 321.7M
- IPO Year
- ORGO N/A
- CHPT N/A
- Fundamental
- Price
- ORGO $2.92
- CHPT $0.69
- Analyst Decision
- ORGO Buy
- CHPT Hold
- Analyst Count
- ORGO 2
- CHPT 10
- Target Price
- ORGO $5.50
- CHPT $1.58
- AVG Volume (30 Days)
- ORGO 1.6M
- CHPT 13.2M
- Earning Date
- ORGO 05-08-2025
- CHPT 06-04-2025
- Dividend Yield
- ORGO N/A
- CHPT N/A
- EPS Growth
- ORGO N/A
- CHPT N/A
- EPS
- ORGO N/A
- CHPT N/A
- Revenue
- ORGO $458,760,000.00
- CHPT $417,083,000.00
- Revenue This Year
- ORGO $2.73
- CHPT $12.03
- Revenue Next Year
- ORGO $12.28
- CHPT $26.85
- P/E Ratio
- ORGO N/A
- CHPT N/A
- Revenue Growth
- ORGO 5.35
- CHPT N/A
- 52 Week Low
- ORGO $2.28
- CHPT $0.51
- 52 Week High
- ORGO $6.71
- CHPT $2.44
- Technical
- Relative Strength Index (RSI)
- ORGO 35.44
- CHPT 52.16
- Support Level
- ORGO $2.61
- CHPT $0.67
- Resistance Level
- ORGO $3.28
- CHPT $0.89
- Average True Range (ATR)
- ORGO 0.14
- CHPT 0.06
- MACD
- ORGO 0.01
- CHPT 0.01
- Stochastic Oscillator
- ORGO 34.59
- CHPT 27.36
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About CHPT ChargePoint Holdings Inc.
ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.